Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816NSE Symbol: NATCOPHARMP/E(TTM):9.79
ISIN Demat:INE987B01026Div & Yield %:0.72EPS(TTM):84.75
Book Value(Rs):461.79599Market Cap ( Cr.):14867.91Face Value(Rs):2
    Change Company 
( In Cr)
ParticularsSep 2025Jun 2025Mar 2025Dec 2024
 Rs CrRs CrRs CrRs Cr
Gross Sales 1264.301192.701157.40407.60
Other Operating Income 0.000.000.000.00
Other Income  93.3059.6062.10168.00
Total Income 1357.601252.301219.50575.60
Total Expenditure  711.80653.00596.20378.20
PBIDT 645.80599.30623.30197.40
Interest  11.702.608.803.40
PBDT 634.10596.70614.50194.00
Depreciation 48.1053.8093.7043.70
Tax 130.60106.0099.4027.90
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -45.50-27.20-6.70-2.50
Reported Profit After Tax 500.90464.10428.10124.90
Extra-ordinary Items  0.000.000.000.00
Adjusted Profit After Extra-ordinary item 500.90464.10428.10124.90
     
EPS (Unit Curr.) 27.9725.9123.906.97
EPS (Adj) (Unit Curr.) 27.9725.9123.906.97
Calculated EPS (Unit Curr.) 27.9825.9323.926.98
Calculated EPS (Adj) (Unit Curr.) 27.9825.9323.926.98
Calculated EPS (Ann.) (Unit Curr.) 111.93103.7195.6627.91
Calculated EPS (Adj) (Ann.) (Unit Curr.) 111.93103.7195.6627.91
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 75.00100.000.0075.00
Equity 35.8035.8035.8035.80
Reserve & Surplus 0.000.000.000.00
Face Value 2.002.002.002.00
     
Public Shareholding (No Of.Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 51.0850.2553.8548.43
PBDTM(%) 50.1550.0353.0947.60
PATM(%) 39.6238.9136.9930.64